Drug policy reformers have been trying to urge U.S. government to revisit current restrictions on scientific research into marijuana’s potential as medicine. The federal government’s strict rules continue to prevent needed studies to  So far, about half of U.S. states allow marijuana for medical use.

he U.S Drug Enforcement Administration (DEA) recently eased up on some restrictions for research evaluating cannabidiol specifically for medicinal use. The modifications will effect the Controlled Substances Act and help researchers follow a protocol  cannabidiol (CBD) for a specific U.S. Food and Drug Administration (FDA)-approved research protocol, the DEA said.